The 10 hottest medtech startups of 2017

Share

Ivenix

Technology: Infusion system

CEO: Stuart Randle

Website: www.ivenix.com

Ivenix is aiming to redesign infusion therapy from the ground up. The company has developed a fully integrated technology to support interoperability and improve safety and performance. Technology within the infusion pump category has been slow to evolve despite an increase in the complexity of drug dosing regimens, demand for hospital EMR integration and persistent patient safety issues.

The company believes every care setting needs to transform infusion therapy. Ivenix is first looking to bring its technology to hospitals. In March, the company secured $50 million in equity financing. This funding will allow the company to pursue FDA clearance and quickly expand its team for commercial launch, as well as some other regulatory milestones.

The Ivenix infusion system is an entirely new pump technology that emphasizes accuracy and efficiency for large volume infusion delivery and management. The platform provides immediate, secure access to patient-specific infusion and pump management information. It features intuitive user interface guides similar to a smartphone.

Next>>

NEW! Technology Track at DeviceTalks Boston

textadimage These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.

View Technology Track Featured Sessions

Register today to save. Use code TECHTRACK to save an additional 10%.

Pages: 1 2 3 4 5 6 7 8 9 10 11

Comments

  1. Heather, great insights on the changing needs for medtech start-ups. We were thrilled to see, Madorra, one of our collaborating partners make your top 10. Look forward to following your updates on this incredible startup space.

    • Heather Thompson says:

      They are doing some important work. Thanks, Juan. I’m excited to see the latest crop of startups for 2018 as well.

Speak Your Mind

*